SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR

KennethJ Leveno, DavidS Guzick, GaryD V. Hankins, VictorR Klein, DavidC Young, M. Lynne Williams

Research output: Contribution to journalArticle

68 Scopus citations

Abstract

106 women between 24 and 33 weeks' gestation and in preterm labour, rigidly defined to include cervical dilatation plus regular uterine contractions, were randomly allocated to receive either intravenous ritodrine hydrochloride or no tocolytic treatment. Ritodrine treatment significantly delayed delivery for 24 hours or less but did not significantly modify the ultimate perinatal consequences of preterm labour.

Original languageEnglish (US)
Pages (from-to)1293-1296
Number of pages4
JournalThe Lancet
Volume327
Issue number8493
DOIs
StatePublished - Jun 7 1986

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR'. Together they form a unique fingerprint.

  • Cite this

    Leveno, K., Guzick, D., Hankins, G. V., Klein, V., Young, D., & Williams, M. L. (1986). SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR. The Lancet, 327(8493), 1293-1296. https://doi.org/10.1016/S0140-6736(86)91219-5